Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8,322 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Phase 1/2 Trial Combining Avelumab and Trabectedin for Advanced Liposarcoma and Leiomyosarcoma.
Wagner MJ, Zhang Y, Cranmer LD, Loggers ET, Black G, McDonnell S, Maxwell S, Johnson R, Moore R, Hermida de Viveiros P, Aicher L, Smythe KS, He Q, Jones RL, Pollack SM. Wagner MJ, et al. Among authors: moore r. Clin Cancer Res. 2022 Jun 1;28(11):2306-2312. doi: 10.1158/1078-0432.CCR-22-0240. Clin Cancer Res. 2022. PMID: 35349638 Free PMC article. Clinical Trial.
Assessment of Doxorubicin and Pembrolizumab in Patients With Advanced Anthracycline-Naive Sarcoma: A Phase 1/2 Nonrandomized Clinical Trial.
Pollack SM, Redman MW, Baker KK, Wagner MJ, Schroeder BA, Loggers ET, Trieselmann K, Copeland VC, Zhang S, Black G, McDonnell S, Gregory J, Johnson R, Moore R, Jones RL, Cranmer LD. Pollack SM, et al. Among authors: moore r. JAMA Oncol. 2020 Nov 1;6(11):1778-1782. doi: 10.1001/jamaoncol.2020.3689. JAMA Oncol. 2020. PMID: 32910151 Free PMC article. Clinical Trial.
Interstitial nephritis associated with indapamide.
Newstead CG, Moore RH, Barnes AJ. Newstead CG, et al. Among authors: moore rh. BMJ. 1990 May 19;300(6735):1344. doi: 10.1136/bmj.300.6735.1344-a. BMJ. 1990. PMID: 2369678 Free PMC article. No abstract available.
A systematic evaluation of the performance and properties of the UK Biobank Polygenic Risk Score (PRS) Release.
Thompson DJ, Wells D, Selzam S, Peneva I, Moore R, Sharp K, Tarran WA, Beard EJ, Riveros-Mckay F, Giner-Delgado C, Palmer D, Seth P, Harrison J, Futema M; Genomics England Research Consortium; McVean G, Plagnol V, Donnelly P, Weale ME. Thompson DJ, et al. Among authors: moore r. PLoS One. 2024 Sep 18;19(9):e0307270. doi: 10.1371/journal.pone.0307270. eCollection 2024. PLoS One. 2024. PMID: 39292644 Free PMC article.
Cohort profile update: the Johns Hopkins HIV clinical cohort, 1989-2023.
Lesko CR, Fojo AT, Keruly JC, Hwang YJ, Falade-Nwulia OO, Zalla LC, Snow LN, Jones JL, Chander G, Moore RD. Lesko CR, et al. Among authors: moore rd. Eur J Epidemiol. 2024 Sep 18. doi: 10.1007/s10654-024-01147-z. Online ahead of print. Eur J Epidemiol. 2024. PMID: 39292312
Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial.
Monk BJ, Barretina-Ginesta MP, Pothuri B, Vergote I, Graybill W, Mirza MR, McCormick CC, Lorusso D, Moore RG, Freyer G, O'Cearbhaill RE, Heitz F, O'Malley DM, Redondo A, Shahin MS, Vulsteke C, Bradley WH, Haslund CA, Chase DM, Pisano C, Holman LL, Pérez MJR, DiSilvestro P, Gaba L, Herzog TJ, Bruchim I, Compton N, Shtessel L, Malinowska IA, González-Martín A. Monk BJ, et al. Among authors: moore rg. Ann Oncol. 2024 Sep 14:S0923-7534(24)03762-1. doi: 10.1016/j.annonc.2024.08.2241. Online ahead of print. Ann Oncol. 2024. PMID: 39284381
8,322 results